AHRQ Child Health Quality Program (CHeQ)

The Institute for Child Health Policy at the University of Florida (UF-ICHP) currently measures and evaluates quality of care for almost 1 in 5 children enrolled in Medicaid and the Children’s Health Insurance Program (CHIP) in the US. We collaborate with the Texas Health and Human Services Commission, the Florida Agency for Health Care Administration, the Florida Healthy Kids Program which oversees CHIP, two Texas Medicaid Managed Care Plans and their health system partners, two dental plans, the OneFlorida Clinical Data Research Network, and two External Quality Review Organization (EQRO) partners. These collaborators joined to form the Child Health Quality (CHeQ) Partnership. We also are partnering with PEDSnet, a national network of children’s hospitals and providers, who will participate in validation for measure refinements that incorporate electronic health record (EHR) data. Through our collaboration experiences, we identified implementation and dissemination opportunities for the following measure sets: 1) Linkage Between Dental Treatment and Dental Prevention and 2) Safe and Judicious Antipsychotic Use in Children and Adolescents. UF-ICHP has a16-year history in both states in measuring children’s quality of care (QOC) and evaluating performance improvement projects. We house fully identified Medicaid and CHIP health care data for all enrolled children from 2007 to the present that are refreshed monthly. Further, we house EHR data in a central repository called the OneFlorida Data Trust for 1.2M or 49% of all children in Florida Medicaid and CHIP, which will be used to enhance the Antipsychotic Use Measure set with metabolic screening and monitoring lab results. We are leveraging our substantial infrastructure and experience to conduct the proposed project and address the required goals as specified in RFA-HS-16-002. The two goals of this project are to test the feasibility and usability of the selected measure sets through: 1) field testing; refining; collecting data, including testing the efficient collection of valuable clinical data from EHRs; and reporting on the measures; and 2) translating the results into QI goals and multi-level performance improvement projects. In addition, we will implement and disseminate leading-edge methods to evaluate and compare quality of care at multiple levels, including the state, health plan, and provider levels. A toolkit, based on lessons learned, that provides practical guidance on how best to design and analyze quality of care data at multiple levels and how to make valid comparisons within and across levels will be developed.

The Child Health Quality Partnership will test and implement new measures to assess the quality of care for children in Medicaid and the Children’s Health Insurance Program in Texas and Florida, two of the three largest states in the US. The results from the quality of care measurements will be translated into quality improvement goals and projects designed to improve the care that children receive. A toolkit focused on the appropriate use of the measures and strategies for improving identified gaps in quality of care will be developed for other states based on lessons learned from this project

Clinical Outcomes by Language of Care in Pediatric Oncology

Although language disparities in outcomes are well documented in general pediatrics and adult oncology, little is known in pediatric oncology. Patient or family language is not included in many multi- institutional databases and patient registries, limiting studies of language-based inequities…

Extreme weather impacts on children’s acute and chronic health outcomes; a multisite study with evaluation of vulnerabilities

The “Extreme Weather and Pediatric Health Outcomes” study investigates the impact of climate change-related extreme weather events, such as extreme heat and heavy rainfall, on children’s health across the United States. This innovative research aims to address critical knowledge gaps…

Characterization of Babies Born with Hemolytic Disease of the Fetus/Newborn (HDFN)

Hemolytic disease of the fetus and newborn (HDFN) otherwise known as erythroblastosis fetalis, is a disease in which fetal and neonatal erythrocytes are destroyed by maternal IgG alloantibodies. Before the first RhD immunoprophylaxis was introduced as a treatment in 1968,…

Scroll to Top